CH541969A - Procédé de fabrication d'une préparation injectable à base de sels d'antibiotiques - Google Patents

Procédé de fabrication d'une préparation injectable à base de sels d'antibiotiques

Info

Publication number
CH541969A
CH541969A CH163972A CH163972A CH541969A CH 541969 A CH541969 A CH 541969A CH 163972 A CH163972 A CH 163972A CH 163972 A CH163972 A CH 163972A CH 541969 A CH541969 A CH 541969A
Authority
CH
Switzerland
Prior art keywords
manufacturing
injectable preparation
preparation based
antibiotic salts
antibiotic
Prior art date
Application number
CH163972A
Other languages
English (en)
Inventor
Dursch Friedrich
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of CH541969A publication Critical patent/CH541969A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CH163972A 1971-02-05 1972-02-04 Procédé de fabrication d'une préparation injectable à base de sels d'antibiotiques CH541969A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11310571A 1971-02-05 1971-02-05
US05/190,325 US3940483A (en) 1971-02-05 1971-10-18 Antibiotic compositions and method

Publications (1)

Publication Number Publication Date
CH541969A true CH541969A (fr) 1973-09-30

Family

ID=26810709

Family Applications (1)

Application Number Title Priority Date Filing Date
CH163972A CH541969A (fr) 1971-02-05 1972-02-04 Procédé de fabrication d'une préparation injectable à base de sels d'antibiotiques

Country Status (9)

Country Link
US (1) US3940483A (fr)
AU (1) AU463408B2 (fr)
BE (1) BE778999A (fr)
CA (1) CA982943A (fr)
CH (1) CH541969A (fr)
DE (1) DE2205272A1 (fr)
ES (1) ES399488A1 (fr)
FR (1) FR2124499B1 (fr)
PH (1) PH11211A (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4001409A (en) * 1975-05-23 1977-01-04 Bristol-Myers Company Injectable formulations of 7-[D-α-amino-α-(p-hydroxyphenyl)acetamido]-3-(1,2,3-triazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid
JPS5329936A (en) * 1976-08-31 1978-03-20 Takeda Chem Ind Ltd Antibiotic composition
US4235900A (en) * 1978-11-15 1980-11-25 E. R. Squibb & Sons, Inc. Cephradine compositions
FR2445833A1 (fr) * 1979-01-04 1980-08-01 Chimie Biolog Nouveaux sels d'antibiotiques amines a cycle beta lactame
IT1124610B (it) * 1979-10-18 1986-05-07 Zambo Spa Mono(2-ammonio-2-idrossimetil-1,3-propandiolo) (2r-cis)-(o-metilossiranil)fosfonato
ES525492A0 (es) * 1982-09-10 1985-02-01 Glaxo Group Ltd Un procedimiento para la produccion de un recipiente hermeticamente cerrado que contiene al menos un antibiotico de beta-lactama.
JPH02500591A (ja) * 1987-05-27 1990-03-01 アクゾ・エヌ・ヴエー β‐ラクタム抗生物質の乾燥した急速溶解性の組成物
IE61679B1 (en) * 1987-08-10 1994-11-16 Fujisawa Pharmaceutical Co Water-soluble antibiotic composition and water-soluble salts of new cephem compounds
DE68922207T2 (de) * 1989-02-06 1995-11-09 Purzer Pharmaceutical Co Verfahren zur Herstellung von Alkalimetall-Salze von 3,7-substituierten 7-Aminocephalosporansauerderivaten.
EP0386951A3 (fr) * 1989-03-06 1992-05-20 Eli Lilly And Company Formulation de diluant pour daptomycin améliorée
US5721229A (en) * 1995-12-26 1998-02-24 Veterinary Pharmacy Corporation Soluble forms of cephalosporins and treatment of animals
US6225304B1 (en) 1999-02-17 2001-05-01 Pharmaceutical Solutions, Inc. Soluble forms of amoxicillin and treatment of animals
US6669929B1 (en) 2002-12-30 2003-12-30 Colgate Palmolive Company Dentifrice containing functional film flakes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB895027A (en) * 1959-08-03 1962-04-26 Bristol Myers Co Therapeutic tetracycline compositions
US3136691A (en) * 1962-03-05 1964-06-09 Astra Pharma Prod Aqueous solution of local anesthetic maintained under pressure
GB1195203A (en) * 1966-06-24 1970-06-17 Glaxo Lab Ltd Cephalosporins
US3485819A (en) * 1968-07-02 1969-12-23 Squibb & Sons Inc Alpha-amino-cyclohexadienylalkylene-penicillins and cephalosporins

Also Published As

Publication number Publication date
FR2124499B1 (fr) 1975-10-10
US3940483A (en) 1976-02-24
FR2124499A1 (fr) 1972-09-22
CA982943A (en) 1976-02-03
PH11211A (en) 1977-10-28
BE778999A (fr) 1972-08-04
AU3867572A (en) 1973-08-09
DE2205272A1 (fr) 1972-08-10
AU463408B2 (en) 1975-07-09
ES399488A1 (es) 1977-05-16

Similar Documents

Publication Publication Date Title
OA03930A (fr) Procédé de préparation d'azapurinones.
OA05107A (fr) Procédé de préparation d'une composition antiparasite à base de 5-propylthio-2-benzimidazolecarrbamate de méthyl.
CH541969A (fr) Procédé de fabrication d'une préparation injectable à base de sels d'antibiotiques
CH531471A (fr) Procédé de fabrication d'un béton
CH534188A (fr) Procédé de préparation d'une composition à base de polyamides
CH525624A (fr) Procédé de fabrication d'une composition aromatisante
OA04087A (fr) Procédé de préparation de nouveaux dérivés à substitution basique de benzylphtalazone et de leurs sels.
CH537921A (fr) Procédé de préparation de nouvelles p-halogéno-phényl-2-pyrrolidinones
OA04093A (fr) Procédé de préparation d'aryl-guanidines ortho-disubstituées.
CH532034A (fr) Procédé de préparation de dibenzo-oxépine-spiro-dioxolannes substiués
BE783017A (fr) Procédé de préparation d'acide alcane sulfonique
BE767030A (fr) Procede de fabrication d'aiguilles monocristallines ou whiskers
CH532567A (fr) Procédé de préparation d'Halogénures de Retinyle
OA03864A (fr) Procédé de préparation d'un médicament à base de P-chlophenoxyisobutyrate de pyridoxine.
BE792733A (fr) Procédé de préparation de polyesters
CH535830A (fr) Procédé de préparation d'antibiotiques
CH508001A (fr) Procédé de fabrication de produits résineux à base de résines polyépoxydes
CH523226A (fr) Procédé de préparation d'a-halogénophénylacétamides
CH487944A (fr) Procédé de préparation d'une composition copolymère à base de chlorure de vinylidène et composition obtenue par ce procédé
CH489557A (fr) Procédé de préparation d'une composition réticulable à base de silicone
CH538467A (fr) Procédé de préparation d'oxyde d'éthylène
CH492017A (fr) Procédé de préparation d'un nouvel antibiotique
CH522590A (fr) Procédé de préparation d'adamantylaminotétrahydronaphtyloxypropanols
CH517765A (fr) Procédé de préparation d'ortho-sulfobenzimides
CH539078A (fr) Procédé de préparation d'une a-phosphonoacétylcéphalosporin

Legal Events

Date Code Title Description
PL Patent ceased